Clinical trial
Saw Palmetto Extract in Benign Prostatic Hyperplasia
NCT00037154 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00037154 |
|---|---|
| Title | Saw Palmetto Extract in Benign Prostatic Hyperplasia |
| Official title | Saw Palmetto Extract In Benign Prostatic Hyperplasia |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Collaborators | National Center for Complementary and Integrative Health (NCCIH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Benign Prostatic Hyperplasia |
| Intervention type | Drug |
| Interventions | Saw Palmetto |
| Enrollment | 224 |
| Start date | Aug 1, 1999 |
| Completion | Dec 1, 2002 |
| First posted | May 17, 2002 |
| Last update posted | Jan 14, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: